4D Molecular Therapeutics, Inc. - stock earnings
FDMT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -32.3 million USD | -19000 USD |
| 2023Q3 | -10.3 million USD | 20.2 million USD |
| 2023Q2 | -29.6 million USD | 239000 USD |
| 2023Q1 | -27.3 million USD | 298000 USD |
| 2022Q4 | -27.3 million USD | 1.2 million USD |
| 2022Q3 | -24.1 million USD | 500000 USD |
| 2022Q2 | -27.4 million USD | 162000 USD |
| 2022Q1 | -26.2 million USD | 1.2 million USD |
| 2021Q4 | -25.1 million USD | 92000 USD |
| 2021Q3 | -22.2 million USD | 1.4 million USD |
| 2021Q2 | -7.6 million USD | 14.6 million USD |
| 2021Q1 | -16.4 million USD | 2.0 million USD |
| 2020Q4 | -20.5 million USD | -977000 USD |
| 2020Q3 | -7.8 million USD | 7.4 million USD |
| 2020Q2 | -15.2 million USD | 3.6 million USD |
| 2020Q1 | -13.2 million USD | 3.5 million USD |
| 2019Q4 | -16.1 million USD | 2.0 million USD |
| 2019Q3 | -16.7 million USD | 540000 USD |
| 2019Q2 | -8.3 million USD | 2.2 million USD |
FDMT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.8 million USD | 20.7 million USD |
| 2022 | -101.1 million USD | 3.1 million USD |
| 2021 | -68.3 million USD | 18.0 million USD |
| 2020 | -56.5 million USD | 13.6 million USD |
| 2019 | -52.9 million USD | 7.0 million USD |
| 2018 | -9.6 million USD | 14.1 million USD |
| 2017 | -11.2 million USD | 5.8 million USD |
FDMT
Price: $26.38
52 week price:
Earnings Per Share: -2.58 USD
P/E Ratio: -12.19
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 192795
Market Capitalization: 1.3 billion